CAPRICOR THERAPEUTICS INC (CAPR)

US14070B3096 - Common Stock

5.47  +0.23 (+4.39%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
240K
-22.58%		2.55M
962.50%		25.178M
887.38%		29.104M
15.59%
EBITDA
YoY % growth
-15.59M
-53.60%		-21.7M
-39.19%		-4.341M
80.00%		-30.396M
-600.21%		N/AN/AN/AN/A
EBIT
YoY % growth
-15.84M
-53.94%		-22.23M
-40.34%		-5.41M
75.66%		-35.04M
-547.70%
Operating Margin
-6,600.00%-871.76%-21.49%-120.39%
EPS
YoY % growth
-0.87
7.45%		N/A-0.87-0.98
-12.84%		N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.12
62.71%
Revenue
Q2Q % growth		9.894M
230.90%
EBITDA
Q2Q % growth		-3.672M
EBIT
Q2Q % growth		-3.883M
52.53%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -0.02
93.55%		-0.090.0778.21%
Q3 2023
Q2Q % growth		 -0.25
3.85%		-0.300.0515.48%
Q2 2023
Q2Q % growth		 -0.29 -0.360.0718.77%
Q1 2023
Q2Q % growth		 -0.31
3.13%		-0.330.025.02%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 12.088M
1,159.18%		10.812M1.276M11.80%
Q3 2023
Q2Q % growth		 6.19M
289.31%		3.228M2.962M91.76%
Q2 2023
Q2Q % growth		 3.92M
∞%		1.53M2.39M156.21%
Q1 2023
Q2Q % growth		 2.99M
∞%		510K2.48M486.27%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 62.22% 4.07% 8.62%
Revenue0% 113.19% 13.23% 23.17%